Whereas TET2 and IDH2 mutations are mutually exclusive in myeloid malignancies [14], TET2 and IDH2 are often co‐mutated in AITL as observed in the present case [13]. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.